These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 882577)

  • 1. The effect of 6-hydroxydopamine on habituation of activity in the developing rat pup.
    Shaywitz BA; Gordon JW; Klopper JH; Zelterman DA
    Pharmacol Biochem Behav; 1977 Apr; 6(4):391-6. PubMed ID: 882577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of apomorphine on escape performance and activity in developing rat pups treated with 6-hydroxydopamine (6-OHDA).
    Lipton SV; McGough JP; Shaywitz BA
    Pharmacol Biochem Behav; 1980 Sep; 13(3):371-7. PubMed ID: 7191569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bromocriptine in developing rat pups after 6-hydroxydopamine.
    Shaywitz BA; Lipton SV; Teicher MH; Cohen DJ; Anderson GM; Batter DK; Young JG
    Pharmacol Biochem Behav; 1981 Sep; 15(3):443-8. PubMed ID: 6794039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup.
    Shaywitz BA; Teicher MH; Cohen DJ; Anderson GM; Young JG; Levitt P
    Psychopharmacology (Berl); 1984; 82(1-2):73-7. PubMed ID: 6420833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of neonatal 6-hydroxydopamine treatment on catecholamine levels and behavior during development and adulthood.
    Fobes JL; Olds ME
    Psychopharmacology (Berl); 1981; 73(1):27-30. PubMed ID: 6785785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phenobarbital on activity and learning in 6-hydroxydopamine treated rat pups.
    Shaywitz BA; Pearson DA
    Pharmacol Biochem Behav; 1978 Aug; 9(2):173-9. PubMed ID: 714967
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effects of maternal and sibling presence of hyperactivity of 6-hydroxydopamine-treated developing rats.
    Teicher MH; Shaywitz BA; Kootz HL; Cohen DJ
    J Comp Physiol Psychol; 1981 Feb; 95(1):134-45. PubMed ID: 7217408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental and biologic interactions on behavior: effects of artificial rearing in rat pups treated with 6-hydroxydopamine.
    Goldenring JR; Shaywitz BA; Wool RS; Batter DK; Anderson GM; Cohen DJ
    Dev Psychobiol; 1982 Jul; 15(4):297-307. PubMed ID: 6809512
    [No Abstract]   [Full Text] [Related]  

  • 9. Open-field behavior in dopamine-depleted rat pups and their mothers.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1983 Feb; 18(2):285-7. PubMed ID: 6403951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of brain biogenic amines, cyclic nucleotides and hyperactivity in 6-OHDA-treated rat pups.
    Concannon JT; Braughler JM; Schechter MD
    Pharmacol Biochem Behav; 1983 Apr; 18(4):477-82. PubMed ID: 6306694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic administration of food colorings on activity levels and cognitive performance in developing rat pups treated with 6-hydroxydopamine.
    Shaywitz BA; Goldenring JR; Wool RS
    Neurobehav Toxicol; 1979; 1(1):41-7. PubMed ID: 551301
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of amphetamine isomers to decrease hyperactivity in developing rats.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1982 Jul; 17(1):5-9. PubMed ID: 7122666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning.
    Archer T; Danysz W; Fredriksson A; Jonsson G; Luthman J; Sundström E; Teiling A
    Pharmacol Biochem Behav; 1988 Oct; 31(2):357-64. PubMed ID: 3149743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogenesis of spontaneous activity and habituation of activity in the rat pup.
    Shaywitz BA; Gordon JW; Klopper JH; Zelterman DA; Irvine J
    Dev Psychobiol; 1979 Jul; 12(4):359-67. PubMed ID: 456762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 6-hydroxydopamine and 6-hydroxydopa on development of behavior.
    Morgan DN; McLean JH; Kostrzewa RM
    Pharmacol Biochem Behav; 1979 Sep; 11(3):309-12. PubMed ID: 504311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
    Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early behavioral and catecholaminergic effects of 6-hydroxydopamine and guanethidine in the neonatal rat.
    Pappas BA; Peters DA; Sobrian AK; Blouin A; Drew B
    Pharmacol Biochem Behav; 1975; 3(4):681-5. PubMed ID: 242015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spontaneous motor activity and radial-maze learning in rats neonatally treated with 6-hydroxydopamine].
    Iwasaki T; Takasuna M
    Yakubutsu Seishin Kodo; 1986 Dec; 6(4):381-8. PubMed ID: 3103348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.